article · Veterinary Medicine and Science
ABSTRACT Background Avian metapneumovirus (aMPV) and infectious laryngotracheitis virus (ILTV) are globally important respiratory pathogens in poultry. However, their serological prevalence has not been established in Ghana. The study therefore sought to serologically detect aMPV and ILTV in commercial poultry in the Ashanti Region of Ghana. Methods This cross‐sectional serological study was conducted in the Ashanti Region, one of the main poultry‐producing zones in Ghana. Antibodies to aMPV and ILTV were determined in serum samples collected from 300 clinically healthy chickens from thirteen large commercial farms, using commercially available indirect ELISA kits (IDvet, France). Results Overall seroprevalence was 49.0% (147/300; 95% CI: 43.3%–54.7%) for aMPV and 7.0% (21/300; 95% CI: 4.4%–10.6%) for ILTV. Farm‐level seroprevalence of aMPV ranged from 0% to 100%, while ILTV ranged from 0% to 40%. Co‐exposure with both viruses was detected in 5.0% (15/300) of birds. Fisher's exact test revealed a statistically significant positive association between aMPV and ILTV seropositivity ( p = 0.041; odds ratio = 2.78; 95% CI: 0.98–8.99). Conclusion The study provides the first serological findings of exposure of aMPV and ILTV in commercial poultry flocks in Ghana. The high levels of aMPV together with the ILTV detection are a true indication that the need to improve respiratory disease surveillance, diagnostic capacity and analyse potential vaccination options of the Ghanaian poultry industry is urgent.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1002/vms3.70971
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.